The yield of monitoring adenovirus in pediatric hematopoietic stem cell transplant patients

References

• Matthes-Martin S, Feuchtinger T, Shaw PJ, et al. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl Infect Dis. 2012;14(6):555–563. doi:10.1111/tid.12022.
   PubMed Web of Science ®Google Scholar
• Mynarek M, Ganzenmueller T, Mueller-Heine A, et al. Patient, virus, and treatment-related risk factors in pediatric adenovirus infection after stem cell transplantation: results of a routine monitoring program. Biol Blood Marrow Transplant. 2014;20(2):250–256. doi:10.1016/j.bbmt.2013.11.009.
   PubMed Web of Science ®Google Scholar
• Watson T, MacDonald D, Song X, et al. Risk factors for molecular detection of adenovirus in pediatric hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2012;18(8):1227–1234. doi:10.1016/j.bbmt.2012.01.013.
   PubMed Web of Science ®Google Scholar
• Kullberg-Lindh C, Mellgren K, Friman V, et al. Opportunistic virus DNA levels after pediatric stem cell transplantation: serostatus matching, anti-thymocyte globulin, and total body irradiation are additive risk factors: opportunistic viral infections after pediatric SCT. Transpl Infect Dis. 2011;13(2):122–130. doi:10.1111/j.1399-3062.2010.00564.x.
   PubMed Web of Science ®Google Scholar
• Öhrmalm L, Lindblom A, Omar H, et al. Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome. Bone Marrow Transplant. 2011;46(2):267–272. doi:10.1038/bmt.2010.86.
   PubMed Web of Science ®Google Scholar
• Lion T, Kosulin K, Landlinger C, et al. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia 2010;24(4):706–714. doi:10.1038/leu.2010.4.
   PubMed Web of Science ®Google Scholar
• Gustafson I, Lindblom A, Yun Z, et al. Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients. J Clin Virol. 2008;43(1):79–85. doi:10.1016/j.jcv.2008.04.014.
   PubMed Web of Science ®Google Scholar
• Yusuf U, Hale GA, Carr J, et al. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 2006;81(10):1398–1404. doi:10.1097/01.tp.0000209195.95115.8e.
   PubMed Web of Science ®Google Scholar
• Walls T, Hawrami K, Ushiro-Lumb I, Shingadia D, Saha V, Shankar AG. Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary? Clin Infect Dis. 2005;40(9):1244–1249. doi:10.1086/429235.
   PubMed Web of Science ®Google Scholar
• Howard DS, Phillips GL, Reece DE, et al. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 1999;29(6):1494–1501. doi:10.1086/313514.
   PubMed Web of Science ®Google Scholar
• George D, El-Mallawany NK, Jin Z, et al. Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality: adenovirus in paediatric allogeneic stem cell transplant. Br J Haematol. 2012;156(1):99–108. doi:10.1111/j.1365-2141.2010.08468.x.
   PubMed Web of Science ®Google Scholar
• Kosulin K, Geiger E, Vécsei A, et al. Persistence and reactivation of human adenoviruses in the gastrointestinal tract. Clin Microbiol Infect. 2016;22(4):381.e1–381.e8. doi:10.1016/j.cmi.2015.12.013.
   Web of Science ®Google Scholar
• Garnett CT, Talekar G, Mahr JA, et al. Latent species C adenoviruses in human tonsil tissues. J Virol. 2009;83(6):2417–2428. doi:10.1128/JVI.02392-08.
   PubMed Web of Science ®Google Scholar
• Echavarria MS, Ray SC, Ambinder R, Dumler JS, Charache P. PCR detection of adenovirus in a bone marrow transplant recipient: hemorrhagic cystitis as a presenting manifestation of disseminated disease. J Clin Microbiol. 1999;37(3):686–689.
   PubMed Web of Science ®Google Scholar
• Robin M, Marque-Juillet S, Scieux C, et al. Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome. Haematologica 2007;92(9):1254–1257.
   PubMed Web of Science ®Google Scholar
• van Tol MJD, Kroes ACM, Schinkel J, et al. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant. 2005;36(1):39–50. doi:10.1038/sj.bmt.1705003.
   PubMed Web of Science ®Google Scholar
• Lion T. Adenovirus Infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev. 2014;27(3):441–462. doi:10.1128/CMR.00116-13.
   PubMed Web of Science ®Google Scholar
• Hiwarkar P, Gaspar HB, Gilmour K, et al. Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients. Bone Marrow Transplant. 2013;48(6):803–808. doi:10.1038/bmt.2012.221.
   PubMed Web of Science ®Google Scholar
• Sandkovsky U, Vargas L, Florescu DF. Adenovirus: current epidemiology and emerging approaches to prevention and treatment. Curr Infect Dis Rep. 2014; 16(8):416. doi:10.1007/s11908-014-0416-y.
   PubMed Web of Science ®Google Scholar
• Echavarria M, Forman M, van Tol MJ, Vossen JM, Charache P, Kroes AC. Prediction of severe disseminated adenovirus infection by serum PCR. The Lancet. 2001;358(9279):384–385. doi:10.1016/S0140-6736(01)05580-5.
   PubMed Web of Science ®Google Scholar
• Schilham MW, Claas EC, van Zaane W, et al. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin Infect Dis. 2002;35(5):526–532. doi:10.1086/341770.
   PubMed Web of Science ®Google Scholar
• Hiwarkar P, Kosulin K, Cesaro S, et al. Management of adenovirus infection in patients after haematopoietic stem cell transplantation: state-of-the-art and real-life current approach: a position statement on behalf of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation. Rev Med Virol. 2018;28(3):e1980. doi:10.1002/rmv.1980.
   PubMed Web of Science ®Google Scholar
• Feghoul L, Chevret S, Cuinet A, et al. Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment. Clin Microbiol Infect. 2015;21(7):701–709. doi:10.1016/j.cmi.2015.03.011.
   PubMed Web of Science ®Google Scholar
• Srinivasan A, Klepper C, Sunkara A, et al. Impact of adenoviral stool load on adenoviremia in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J. 2015;34(6):562–565. doi:10.1097/INF.0000000000000678.
   PubMed Web of Science ®Google Scholar
• Kosulin K, Berkowitsch B, Matthes S, et al. Intestinal adenovirus shedding before allogeneic stem cell transplantation is a risk factor for invasive infection post-transplant. EBioMedicine 2018;28:114–119. doi:10.1016/j.ebiom.2017.12.030.
   PubMed Web of Science ®Google Scholar
• Feuchtinger T, Lücke J, Hamprecht K, et al. Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br J Haematol. 2005;128(4):503–509. doi:10.1111/j.1365-2141.2004.05331.x.
   PubMed Web of Science ®Google Scholar
• Bhadri VA, Lee-Horn L, Shaw PJ. Safety and tolerability of cidofovir in high-risk pediatric patients. Transpl Infect Dis. 2009;11(4):373–379. doi:10.1111/j.1399-3062.2009.00391.x.
   PubMed Web of Science ®Google Scholar
• Grimley MS, Chemaly RF, Englund JA, et al. Brincidofovir for asymptomatic adenovirus viremia in pediatric and adult allogeneic hematopoietic cell transplant recipients: a randomized placebo-controlled phase II trial. J Am Soc Blood Marrow Transplant. 2017;23(3):512–521. doi:10.1016/j.bbmt.2016.12.621.
   PubMed Web of Science ®Google Scholar
• Hiwarkar P, Amrolia P, Sivaprakasam P, et al. Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant. Blood 2017;129(14):2033–2037. doi:10.1182/blood-2016-11-749721.
   PubMed Web of Science ®Google Scholar
• Leen AM, Christin A, Myers GD, et al. Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood 2009;114(19):4283–4292. doi:10.1182/blood-2009-07-232454.
   PubMed Web of Science ®Google Scholar
• Sarantis H, Johnson G, Brown M, Petric M, Tellier R. Comprehensive detection and serotyping of human adenoviruses by PCR and sequencing. J Clin Microbiol. 2004;42(9):3963–3969. doi:10.1128/JCM.42.9.3963-3969.2004.
   PubMed Web of Science ®Google Scholar
• Lindemans CA, Leen AM, Boelens JJ. How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood 2010;116(25):5476–5485. doi:10.1182/blood-2010-04-259291.
   PubMed Web of Science ®Google Scholar
• Lion T. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 2003;102(3):1114–1120. doi:10.1182/blood-2002-07-2152.
   PubMed Web of Science ®Google Scholar
• Kampmann B, Cubitt D, Walls T, et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol. 2005;130(4):595–603. doi:10.1111/j.1365-2141.2005.05649.x.
   PubMed Web of Science ®Google Scholar
• Leruez-Ville M, Minard V, Lacaille F, et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis. 2004;38(1):45–52. doi:10.1086/380450.
   PubMed Web of Science ®Google Scholar
• Anderson EJ, Guzman-Cottrill JA, Kletzel M, et al. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. Pediatr Transplant. 2008;12(2):219–227. doi:10.1111/j.1399-3046.2007.00851.x.
   PubMed Web of Science ®Google Scholar
• Sivaprakasam P, Carr TF, Coussons M, et al. Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention. J Pediatr Hematol Oncol. 2007;29(2):81–85. doi:10.1097/MPH.0b013e318030875e.
   PubMed Web of Science ®Google Scholar
• Kalpoe JS, Van P, der H, Barge RM, et al. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning. Eur J Haematol. 2007;78(4):314–321. doi:10.1111/j.1600-0609.2007.00821.x.
   PubMed Web of Science ®Google Scholar
• Omar H, Yun Z, Lewensohn, I et al. Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia. Transpl Infect Dis. 2010;12(5):465–469. doi:10.1111/j.1399-3062.2010.00528.x.
   PubMed Web of Science ®Google Scholar
• Suparno C, Milligan DW, Moss PAH, Mautner V. Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management. Leuk Lymphoma. 2004;45(5):873–885. doi:10.1080/10428190310001628176.
   PubMed Web of Science ®Google Scholar
• Walls T, Hawrami K, Shingadia D, Ushiro-Lumb I, Shankar A. Polymerase chain reaction in the management of disseminated adenovirus infection after stem cell transplantation. Pediatr Infect Dis J. 2004;23(12):1167–1169. doi:10.1097/01.inf.0000145407.56083.89.
   PubMed Web of Science ®Google Scholar
• Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15(10):1143–1238. doi:10.1016/j.bbmt.2009.06.019.
   PubMed Web of Science ®Google Scholar